Status:
COMPLETED
Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia
Lead Sponsor:
Oregon Health and Science University
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18+ years
Brief Summary
Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can ...
Detailed Description
The main outcome measure of this study are measurements taken every half hour during an inpatient study visit. These measurements include standing on a forceplate for 1 minute while performing a menta...
Eligibility Criteria
Inclusion
- Parkinsons disease
- Older than 18
Exclusion
- Must be participating in a Parkinsons disease study at Oregon Health \& Science University
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00912977
Start Date
June 1 2009
End Date
June 1 2010
Last Update
September 30 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97201